EMT and Inflammation: Crossroads in HCC

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
• Chronic inflammation, often from hepatitis B/C, alcohol, or metabolic syndrome, underlies most HCC development.
• Epithelial-mesenchymal transition (EMT) is a cellular process regulated by growth factors and cytokines, implicated in tumor aggressiveness.

Purpose of the Study:

• To review recent findings on the association between EMT and inflammation in HCC progression.
• To explore the role of cellular heterogeneity in HCC development and chemoresistance.
• To identify potential EMT-related biomarkers for predicting metastasis.

Main Methods:

• Literature review of recent developments in HCC research.
• Analysis of the interplay between EMT, inflammation, and the tumor microenvironment.
• Discussion of regulatory molecules and biomarkers associated with EMT in HCC.

Main Results:

• EMT and inflammation are strongly correlated with HCC aggressiveness and poor patient outcomes.
• Cellular heterogeneity, arising from EMT and inflammation, drives HCC progression and chemoresistance.
• EMT and inflammation are key factors in the complex development of HCC.

Conclusions:

• The interplay between EMT and inflammation is critical in HCC progression.
• Identifying EMT biomarkers and understanding regulatory pathways are crucial for clinical applications.
• Targeting EMT and inflammation may offer new strategies for HCC treatment and metastasis prediction.